9th International Adrenal Cancer Symposium

The 9th International Adrenal Cancer Symposium marks the latest installment in a series of successful global gatherings, with each previous event drawing an impressive assembly of 150-250 participants from across the world. These symposia traditionally encompass a comprehensive range of sessions, spanning both clinical and non-clinical sessions. In this symposium, we aspire to enhance the inclusivity and relevance of the event by introducing a dedicated session tailored specifically for patients and their families. This initiative aims to provide valuable insights, support, and information directly to those impacted by adrenal cancer.

Abstracts and Awards
Join us and present your latest research in Houston for the 9th International Adrenal Cancer Symposium! This event brings together the world leaders in adrenocortical carcinoma, offering a platform to present your work. 

Abstract Deadlines:

• Abstract submission opens: June 15, 2024
• Abstract submission deadline: September 30th, 2024
• Abstract notification date: October 18, 2024

Abstract Categories:

• Clinical
• Translational

Submission - All abstracts must be submitted electronically via email to Vania Balderrama Brondani, [email protected].

• Prior Publication and Presentation - The data in the submitted abstract cannot have been published or presented at another international scientific meeting.
• Number of Abstracts - Authors can submit an unlimited number of abstracts.
• Number of Authors - There is no limit on the number of authors on an abstract.
• MEETING REGISTRATION AND PRESENTATION REQUIRED An author of the abstract is required to register and present in person at the meeting

Fees
Abstract submission is free

Scientific Abstracts
Scientific abstracts  must be submitted as a PDF file and include Background, Objectives, Methods, Results, and Discussion/Conclusion. The word limit is 350 words, and only one table is allowed per abstract. The abstracts must be submitted in English.  

The Program Committee will carefully select abstracts to be nominated for posters or oral presentation (10 minutes). The program committee will select the top three (3) abstracts of each category. 

Abstract Awards
Thanks to generous support, the symposium will assist with lodging to attend the symposium for up to 25 participants.  The Symposium will cover the cost of three (3) nights at the host hotel (room & tax) as well an abstract award of $1,500 USD for international participants and $750 USD for US participants.

Eligibility:

• Applicants must be a trainee, resident, fellow, or student.  
• Applicants must register for the symposium by September 30, 2024.
• Applicants must be a first author AND presenter of a submitted abstract.

1. Identify molecular targets for future translational and clinical research.
2. Discuss the appropriate treatment options for both localized and advanced cases of adrenal cancer based on individual patient characteristics.
3. Develop effective communication and counseling skills for educating patients and their families about adrenal cancer diagnosis, prognosis, and comprehensive management strategies.

9th International Adrenal Cancer Symposium - November 22-23, 2024.  The symposium will begin at 7:30 AM, Friday, November 22, 2024 and will adjourn at 5:00 PM, Saturday, November 22, 2024.  Location: Dan L. Duncan Building, 1155 Pressler Street, Floor 8, Houston, TX 77030, Conference Center Rooms 1-8.

Registration fee includes tuition for the in-person Live Activity. Advanced registration is encouraged - The deadline for advanced registration is October 22, 2024.

Registration Category Fee:

We accept the following forms of payment:

• Credit Cards (MasterCard, VISA, and American Express)
• Check (payable through U.S. banks only)
• Mail to: Continuing Professional Education – Unit 1781, The University of Texas MD Anderson Cancer Center, P.O. Box 301407, Houston, TX 77230-1407

Make check payable to:  The University of Texas MD Anderson Cancer Center

When registering online a receipt (confirmation letter) will be automatically emailed to the e-mail address you list on the registration form.

REFUND/CANCELLATION POLICY
The registration fee, minus a $50 administrative handling fee, is refundable if a written request is received on or before Tuesday, October 22, 2024.  No refunds will be granted after that date.  The request for a registration refund must include the tax identification number of the company or institution if registration was paid by a company or institution check.  For additional information, contact Continuing Professional Education at 713-792-2223 or toll free at 866-849-5866.

Continuing Professional Education reserves the right to cancel activities prior to the scheduled date, if low enrollment or other circumstances make it necessary.  Each registrant will be notified by mail, e-mail, or at the phone or fax numbers given on the registration form.

In case of activity cancellation, the liability of Continuing Professional Education is limited to the registration fee. Continuing Professional Education will refund the full registration fee.

Continuing Professional Education reserves the right to limit the number of participants in a program and is not responsible for any expenses incurred by an individual whose registration is not confirmed and for whom space is not available. 

Please let us know what specific topics, issues, or questions you wish to see addressed or emphasized in this activity by emailing Continuing Professional Education at [email protected]. All responses will be forwarded to the Program Directors for consideration.  

SPECIAL ASSISTANCE
Contact Continuing Preofessional Education/Activity Management  at 713-745-0083 or 866-849-5866, if you have any ADA accommodation needs.

GROUND TRANSPORTATION:
Houston is served by two airports, George Bush Intercontinental (IAH) and William P. Hobby (HOU).  The following ground transportations are available to and from the airports to the Medical Center.
     • Uber and Lyft
     • Taxicabs: Yellow Cab 713-236-1111; Fiesta Cab 713-225-2666.
     • Super Shuttle: For more information, call toll free at 800-258-3826, or on-line at www.supershuttle.com.

EVALUATION:
A course evaluation tool will provide participants with the opportunity to comment on the value of the program content to their practice decisions, performance improvement activities, or possible impact on patient health status. Participants will also have the opportunity to comment on any perceived commercial bias in the presentations as well as to identify future educational topics.  The survey link will be provided during the review course.

For additional information or Special Assistance, contact CPE at 713-792-2223 or toll free at 866-849-5866 or via e-mail: [email protected].

In support of improving patient care, The University of Texas MD Anderson Cancer Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

View the accessibility policy for The University of Texas M.D Anderson Cancer Center.

9th International Adrenal Cancer Symposium Room Block

Houston Marriott Medical Center/Museum District
6580 Fannin Street, Houston, TX 77030
T: 713.796.0080

Start Date: Thursday, Nov. 21, 2024
End Date: Saturday, Nov. 23, 2024

Last Day to Book at Group Rate of $159/night: Thursday, Oct. 24, 2024

Group Code: IACIACR
Book your group rate for 9th Int'l Adrenal Cancer Symp

Texas Medical Center (TMC) / Museum District Area Attractions

• Houston Zoo
• Hermann Park
• Miller Outdoor Theatre
•  Japanese Garden
•  Houston Museum of Natural Science
•  The Museum of Fine Arts, Houston
•  Children's Museum Houston
•  Cockrell Butterfly Center

The University of Texas MD Anderson Cancer Center complies with all requirements of the identified accrediting body  (ACCME, ANCC, ACPE). Disclosure of speakers, faculty members, planning committee members and their commercial relationships will be shared with learners prior to the educational activity.

Mitigation of Relevant Financial Relationships

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

Eric Gagneaux
Continuing Education Planner
MD Anderson Cancer Center

Activity Administrator

Nothing to disclose

Matthew T Campbell, MD
Associate Professor
MD Anderson Cancer Center

Co-Director, Faculty

Advisor-Eisai, Inc. (Relationship has ended)|Speakers Bureau-Curio Science|Speakers Bureau-MJH Life Sciences|Advisor-Pfizer Inc. (Relationship has ended)|Consulting Fee-Exelixis (Relationship has ended)|Consulting Fee-Seattle Genetics, Inc. (Relationship has ended)|Grant or research support-Seattle Genetics, Inc.|Advisor-AXDev (Relationship has ended)|Grant or research support-Exelixis|Grant or research support-Pfizer Inc.|Grant or research support-Janssen Biotech, Inc.|Grant or research support-Aravive|Grant or research support-AstraZeneca US|Grant or research support-ApricityHealth (Relationship has ended)

Jeffrey E Lee, MD
Chair
MD Anderson Cancer Center

Co-Director, Faculty

Nothing to disclose

Mouhammed Amir Habra, MD
Professor
MD Anderson Cancer Center

Course Director, Faculty

Honoraria-Calico (Relationship has ended)|Grant or research support-Exelixis (Relationship has ended)|Honoraria-HRA pharma (Relationship has ended)|Consulting Fee-Recordati (Relationship has ended)

Barbara Altieri, MD, PhD
Dr.
University Hospital of Würzburg
Germany

Faculty

Nothing to disclose

Guillaume Assié, MD, PhD
Institut Cochin, Paris, France
France

Faculty

Other: Speaker in a symposium-Pfizer Inc. (Relationship has ended)|Other: Speaker in a symposium-HRA pharma (Relationship has ended)

Richard Auchus, MD, PhD
Professor
University of Michigan

Faculty

Consulting Fee-Quest Diagnostics Corcept Therapeutics Xeris Pharmaceuticals Crinetics Pharmaceuticals Novo Nordisk|Consulting Fee-Neurocrine Biosciences Recordati Rare Diseases H Lundbeck AS Sparrow Pharmaceuticals|Grant or research support-Neurocrine Biosciences Durnal LTD Spruce Biosciences |Grant or research support-Corcept Therapeutics Crinetics Pharmaceuticals Recordati Rare Diseases Adrenas Therapeutics |Grant or research support-Mineralys Pharmaceuticals

Kaitlin Basham, PhD
University of Utah

Faculty

Nothing to disclose

Alfredo Berruti, MD
Full Professor Medical Oncology
University of Brescia
Italy

Faculty

Speakers Bureau-Johnson & Johnson (any division) (Relationship has ended)|Grant or research support-Sanofi Genzyme (Relationship has ended)

Felix Beuschlein, MD
Prof. Dr.
University Hospital Zurich
Switzerland

Faculty

Nothing to disclose

David T Breault, MD, PhD
Associate Professor
Boston Children's Hospital

Faculty

Nothing to disclose

Vasileios Chortis, MD, PhD
Associate Professor of Endocrinology
University of Birmingham
United Kingdom

Faculty

Nothing to disclose

Anthony P Conley, MD
Associate Professor
University of Texas MD Anderson Cancer Center

Faculty

Grant or research support-Chordoma Foundation|Paid consultant-Aadi Biosciences|Grant or research support-CRI|Grant or research support-Bavarian Nordic (Relationship has ended)|Grant or research support-NantPharma (Relationship has ended)|Grant or research support-Lilly USA, LLC|Grant or research support-NCI|Grant or research support-Roche|Paid consultant-Applied Clinical Intelligence|Paid consultant-Deciphera|Paid consultant-Inhibrix|Grant or research support-Inhibrix|Grant or research support-Epicentrx|Paid consultant-Ipsen US (Relationship has ended)|Grant or research support-Krystal Biotech|Grant or research support-Kronos Bio

Joakim Crona, MD, PhD
Uppsala University
Sweden

Faculty

Nothing to disclose

Rodrigo De Almeida Toledo, PhD
PhD, MBA
Vall d'Hebron Institute of Oncology (VHIO)
Spain

Faculty

Grant or research support-Novartis Pharmaceuticals Corporation|Grant or research support-BeiGene|Grant or research support-AstraZeneca US

Guido Di Dalmazi, MD
University of Bologna
Italy

Faculty

Membership on Advisory Committees or Review Panels, Board Membership, etc.-Novo Nordisk

Keith D Eaton, MD, PhD
Professor
Fred Hutchinson Cancer Center

Faculty

Grant or research support-Mirati Therapuetics (Relationship has ended)

Tobias Else, MD
University of Michigan

Faculty

Advisor-Merck Sharp & Dohme Corp. (any division)

Martin Fassnacht, MD
Chair
University Hospital Würzburg
Germany

Faculty

Nothing to disclose

Lauren Fishbein, MD, PhD, MD, PhD
University of Colorado

Faculty

Nothing to disclose

Thomas Giordano, MD, PhD
Professor
University of Michigan

Faculty

Nothing to disclose

Karen E Gomez Hernandez, MD
Assistant Professor/Staff Endocrinologist
University of Toronto, University Health Network, and Mount Sinai Hospital
Canada

Faculty

Nothing to disclose

Gary D Hammer, MD, PhD
Millie Schembechler Professor of Adrenal Cancer, Director – Endocrine Oncology Program
University of Michigan

Faculty

Nothing to disclose

Amir H Hamrahian, MD
Associate Professor of Medicine
Johns Hopkins University

Faculty

Consulting Fee-Corcept|Advisor-HRA Pharma (Relationship has ended)

Inga Harbuz-Miller, MD
Assistant Professor
University of Rochester

Faculty

Nothing to disclose

Jonathan Hernandez, MD
Principal Investigator
NIH

Faculty

Nothing to disclose

H. Courtney Hodges, PhD
Associate Professor
Baylor College of Medicine

Faculty

Nothing to disclose

Marybeth S Hughes, MD
Margaret Moore Hall Chair of Surgical Oncology
Eastern Virginia Medical School

Faculty

Nothing to disclose

Anne Jouinot, MD, PhD
Inserm
France

Faculty

Nothing to disclose

Electron Kebebew, MD
MD
Stanford University

Faculty

Nothing to disclose

Lawrence S Kirschner, MD, PhD
Dr.
NIEHS

Faculty

Membership on Advisory Committees or Review Panels, Board Membership, etc.-Corcept Therapeutics (Relationship has ended)|Grant or research support-Crinetics (Relationship has ended)|Grant or research support-Sparrow Pharma (Relationship has ended)|Grant or research support-Spruce Pharma (Relationship has ended)|Grant or research support-AstraZeneca US (Relationship has ended)

Katja Kiseljak-Vassiliades, DO
University of Colorado School of Medicine

Faculty

Membership on Advisory Committees or Review Panels, Board Membership, etc.-HRAPharma (Relationship has ended)

Alexander Kutikov, MD
Chair
Fox Chase Cancer Center

Faculty

Nothing to disclose

Andre Lacroix, MD
Professor
Centre hospitalier, Université de Montréal
Canada

Faculty

Nothing to disclose

Marta Laganà, MD
University of Brescia
Italy

Faculty

Nothing to disclose

Laura-Sophie Landwehr, PhD
Dr.
University Hospital Würzburg
Germany

Faculty

Nothing to disclose

Antonio Lerario, MD, PhD
University of Michigan

Faculty

Nothing to disclose

Travis McKenzie, MD
Professor of Surgery
Mayo Clinic

Faculty

Nothing to disclose

Ozgur Mete, MD, FRCPC
Prof
University Health Network, University of Toronto
Canada

Faculty

Nothing to disclose

Barbra Miller, MD
Clinical Professor of Surgery
The Ohio State University

Faculty

Honoraria-Corcept (Relationship has ended)

Levent Ozsari, MD, Endocrinology
University of Saglik Bilimleri Haydarpasa Numune Hospital
Turkey

Faculty

Nothing to disclose

Emilia M Pinto, PhD
PhD
St. Jude Children's Research Hospital

Faculty

Nothing to disclose

Yves Pommier, MD, PhD
NIH

Faculty

Nothing to disclose

Raul Ribeiro, MD
Member
St. Jude Children's Research Hospital

Faculty

Nothing to disclose

Rahul Sheth, MD
UT MD Anderson

Faculty

Consulting Fee-Trisalus|Grant or research support-Boston Scientific Corporation|Consulting Fee-Medtronic, Inc. (any division)|Consulting Fee-Replimune|Consulting Fee-Varian Medical Systems, Inc

Rosa Sirianni, PhD
University of Calabria
Italy

Faculty

Nothing to disclose

Constantine A Stratakis, MD, PhD
Professor
FORTH
Greece

Faculty

Grant or research support-Pfizer Inc.|Consulting Fee-STEROTHERAPEUTICS|Executive-Healthspan Digital|Independent Contractor (included contracted research)-Human Longevity

Sumit K Subudhi, MD, PhD
Associate Professor
UT MD Anderson Cancer Center

Faculty

Nothing to disclose

Pierre Val, PhD
Dr
CNRS
France

Faculty

Nothing to disclose

Rena Vassilopoulou-Sellin, MD
dr
n/a

Faculty

Nothing to disclose

Weiqing Wang, MD
Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
China

Faculty

Nothing to disclose

Margaret E Wierman, MD
Professor
University of Colorado

Faculty

Nothing to disclose

Vania Balderrama Brondani, MD, PhD
MDAnderson Cancer Center

Faculty, Other Planning Committee Member

Nothing to disclose

Hubert Chuang, MD, PhD
MDAnderson

Faculty, Other Planning Committee Member

Nothing to disclose

Eleonora Dondossola, PhD
UT MD Anderson Cancer Center

Faculty, Other Planning Committee Member

Nothing to disclose

Khaled Elsayes, MD
Professor
MD Anderson Cancer Center

Faculty, Other Planning Committee Member

Nothing to disclose

Sarah B. Fisher, MD
Assistant Professor
The University of Texas MD Anderson Cancer Center

Faculty, Other Planning Committee Member

Nothing to disclose

MARIA CANDIDA BARISSON VILLARES FRAGOSO, MD, PhD, Professor
Prof
Hospital das Clinicas of University of Sao Paulo - ICESP
Brazil

Faculty, Other Planning Committee Member

Nothing to disclose

Paul Graham, MD
UT MD Anderson Cancer Center

Faculty, Other Planning Committee Member

Nothing to disclose

Camilo Jimenez, MD
Professor
The University of Texas MD Anderson Cancer Center

Faculty, Other Planning Committee Member

Grant or research support-Merck Sharp & Dohme Corp. (any division)|Grant or research support-Lantheus Pharmaceuticals|Grant or research support-Exelixis|Advisor-Merck Sharp & Dohme Corp. (any division)|Advisor-Lantheus

Enzo Lalli, MD
Inserm
France

Faculty, Other Planning Committee Member

Nothing to disclose

John Lin, MD
MD Anderson Cancer Center

Faculty, Other Planning Committee Member

Nothing to disclose

Chaan Ng, MD
Dr
MDACC

Faculty, Other Planning Committee Member

Consulting Fee-GE Healthcare (Relationship has ended)

Nancy D. Perrier, MD
Professor of Surgery
MD Anderson Cancer Center

Faculty, Other Planning Committee Member

Nothing to disclose

Cristina Ronchi, MD, PhD
University of Birmingham
United Kingdom

Faculty, Other Planning Committee Member

Grant or research support-HRA Pharma Rare Disease

Amishi Yogesh Shah, MD
Assistant Professor
The University of Texas MD Anderson Cancer Center

Faculty, Other Planning Committee Member

Grant or research support-Bristol-Myers Squibb Company|Grant or research support-EMD Serono Inc.|Grant or research support-Eisai, Inc. (Relationship has ended)|Grant or research support-4D pharma (Relationship has ended)|Advisor-Bristol-Myers Squibb Company (Relationship has ended)|Advisor-exelixis (Relationship has ended)|Advisor-Pfizer Inc. (Relationship has ended)

Kanishka Sircar, MD
Professor
University of Texas MD Anderson Cancer Center

Faculty, Other Planning Committee Member

Nothing to disclose

Massimo Terzolo, MD
Prof.
University of Turin
Italy

Faculty, Other Planning Committee Member

Advisor-HRA Rare Diseases|Consulting Fee-Recordati Rare Diseases|Consulting Fee-Corcept Therapeutics (Relationship has ended)

Jeena Varghese, MD
Assistant Professor - Endocrine Neoplasia and HD
The University of Texas MD Anderson Cancer Center

Faculty, Other Planning Committee Member

Nothing to disclose

Steven G Waguespack, MD
Professor
University of Texas MD Anderson Cancer Center

Faculty, Other Planning Committee Member

Consulting Fee-Bayer HealthCare Pharmaceuticals, Inc.

Miao Zhang, MD
Dr.
MD Anderson Cancer Center

Faculty, Other Planning Committee Member

Nothing to disclose

Marta Lagana, MD
MD
MDACC Reseach Resident/Resident Univ of Breascia, Italy

Other Planning Committee Member

Nothing to disclose

Disclaimer: By clicking on "Exhibitors" you have left the accredited educational content of the course.

 

The University of Texas MD Anderson Cancer Center wishes to express appreciation to the following companies:

 

Diamond Level
HRA Pharma Rare Diseases

Bronze Level
Eisai
Recordati Rare Diseases

Exhibitor Level
Corcept Therapeutics
Merck

-------------------------------------------------------------------------------------------------------------------------------------------------